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Abstract
Background: The level of antibodies against PfEMP1 is routinely quantified by the conventional microtitre enzyme-linked
immunosorbent assay (ELISA). However, ELISA only measures one analyte at a time and requires a relatively large plasma
volume if the complete antibody profile of the sample is to be obtained. Furthermore, assay-to-assay variation and the problem
of storage of antigen can influence ELISA results. The bead-based assay described here uses the BioPlex100 (BioRad, Hercules,
CA, USA) system which can quantify multiple antibodies simultaneously in a small plasma volume.
Methods: A total of twenty nine PfEMP1 domains were PCR amplified from 3D7 genomic DNA, expressed in the Baculovirus
system and purified by metal-affinity chromatography. The antibody reactivity level to the recombinant PfEMP1 proteins in
human hyper-immune plasma was measured by ELISA. In parallel, these recombinant PfEMP1 proteins were covalently coupled
onto beads each having its own unique detection signal and the human hyper-immune plasma reactivity was detected for each
individual protein using a BioPlex100 system. Protein-coupled beads were analysed at two time points seven months apart, before
and after lyophilization and the results compared to determine the effect of storage and lyophilization respectively on the beads.
Multiplexed protein-coupled beads from twenty eight unique bead populations were evaluated on the BioPlex100 system against
pooled human hyper-immune plasma before and after lyophilization.
Results: The bead-based assay was sensitive, accurate and reproducible. Four recombinant PfEMP1 proteins C17, D5, D9 and
D12, selected on the basis that they showed a spread of median fluorescent intensity (MFI) values from low to high when
analysed by the bead-based assay were analysed by ELISA and the results from both analyses were highly correlated. The
Spearman's rank correlation coefficients (Rho) were ≥ 0.86, (P < 0.0001) for all comparisons. Bead-based assays gave similar
results regardless of whether they were performed on individual beads or on multiplexed beads; lyophilization had no impact
on the assay performance. Spearman's rank correlation coefficients (Rho) were ≥ 0.97, (P < 0.0001) for all comparisons.
Importantly, the reactivity of protein-coupled non-lyophilized beads decreased with long term storage at 4°C in the dark.
Conclusion: Using this lyophilized multiplex assay, antibody reactivity levels to twenty eight different recombinant PfEMP1
proteins were simultaneously measured using a single microliter of plasma. Thus, the assay reported here provides a useful tool
for rapid and efficient quantification of antibody reactivity against PfEMP1 variants in human plasma.
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Background
The hope of developing a vaccine against malaria is based
on evidence that clinical immunity to the disease is devel-
oped through repeated exposures over several years to the
pathogen [1]. Several studies suggest that protective
immunity to malaria develop partly through the acquisi-
tion of a wide repertoire of specific antibodies directed
against the polymorphic antigen target, Plasmodium falci-
parum erythrocyte membrane protein 1 (PfEMP1) [2,3].
To date, anti-PfEMP1 antibody levels in human plasma
samples have been measured using enzyme-linked immu-
nosorbent assay (ELISA). As P. falciparum malaria pre-
dominantly affects individuals of young age, studies of
malaria immunity rely on plasma samples from infants
and toddlers. This creates a limitation in using ELISA as
obtainable plasma volumes from these target groups are
relatively small. In addition ELISA is time consuming and
labor intensive. Recent technological advances have
resulted in the development of high-throughput multi-
plex methods which enable the simultaneous detection of
antibodies to multiple analytes in human plasma sam-
ples.
Vignali [4] described the use of the Luminex100 system, a
bench-top flow cytometer equipped with two low power
laser beams and capable of performing 100 discrete assays
simultaneously in a single well. Each bead set is impreg-
nated with a unique ratio of red-to-infrared dyes. When
excited, each bead set emits its own unique detection sig-
nal that can be resolved by the instrument. Molecules cov-
alently coupled to the beads, such as recombinant
PfEMP1 proteins, can be detected by the use of a bioti-
nylated secondary antibody with phycoerythrin-conju-
gated streptavidin used as a reporter.
Several studies have reported the use of multiplex assays
to measure cytokine levels in samples [5], antibody levels
to protein antigens [6] and antibodies to multiple malaria
vaccine candidate antigens [7].
The assay reported here for evaluating the antibody profile
of human plasma samples is based on a multiplex of
twenty eight recombinant PfEMP1 protein coupled beads,
each bead population with its own unique detection sig-
nal. The assay, requires one microliter of plasma sample
for measuring antibodies to all twenty eight recombinant
PfEMP1 proteins, is reproducible, gives results compara-
ble to ELISA and is high-throughput. Importantly, the
coupled beads remained stable after lyophilization and
storage at -80°C.
Materials and methods
Reagents
1-ethyl-3-[3dimethylaminopropyl] carbodiimide hydro-
chloride (EDC) and N-hydroxysulfosuccinimide
(Sulfo_NHS) were purchased from Pierce Biotechnology
(Rockford, IL). 2-[N-morpholino] ethanesulfonic acid
(MES), Tween-20, bovine serum albumin (BSA) sodium
azide, biotinylated anti-human IgG, biotinylated anti-V5
antibody and phycoerythrin conjugated streptavidin were
purchased from Sigma-Aldrich, USA.
Plasma samples
The hyper-immune plasma pool was made up of plasma
from ten individuals from a malaria endemic area of Libe-
ria. Twenty samples from Danes who have never had
malaria were used to make up the naïve pool. Sixty indi-
vidual plasma samples, twenty each from people living in
the three Tanzanian villages Mgome, Ubiri and Magamba
with high, moderate and low malaria transmission [8],
respectively were also analysed.
Protein expression
Protein expression was as described previously [9,10].
Briefly, primer pairs designed to contain restriction
enzyme sites (See additional file 1) were used to amplify
Cysteine-rich inter-domain regions (CIDR) and Duffy
binding-like (DBL) domains from 3D7 genomic DNA.
The digested PCR products were cloned into the Baculovi-
rus  vector, pAcGP67-A (BD Bioscience), which was
designed to contain the V5 epitope upstream of a histi-
dine tag in the C-terminal end of the construct. The iden-
tity of the cloned fragments was verified by sequencing.
Linearized Bakpak6 Baculovirus DNA (BD Biosciences
Clontech) was co-transfected with pAcGP67-A into Sf9
insect cells for generation of recombinant virus particles
and histidine-tagged proteins secreted into the superna-
tant of infected High-Five insect cell were purified on Co2+
metal-chelate agarose columns. Eluted products were dia-
lysed overnight in PBS. The yield, integrity and purity of
the recombinant proteins were estimated by analysis on
SDS gel, comparing to BSA standards, and by western
blotting using the anti-V5 antibody. All of the proteins
coupled to the Luminex beads were estimated to be at or
above 80% purity. The sizes of the different recombinant
proteins ranged from 45 to 60 kDa.
Covalent coupling of recombinant PfEMP1 proteins to 
beads
Carboxylated Luminex beads were covalently coated with
the different PfEMP1 protein domains through an interac-
tion of their carboxyl groups and the amino groups on the
proteins following the procedure suggested by the manu-
facturer. Beads (1.25 × 107 beads/ml) were brought to
room temperature, vortexed for one minute and trans-
ferred to Eppendorf® tubes. The supernatant was removedMalaria Journal 2008, 7:108 http://www.malariajournal.com/content/7/1/108
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after centrifugation for one minute at 16,000 × g. 1 ml of
distilled water was added to the beads, vortexed to re-sus-
pend followed by centrifugation for one minute at 16,000
× g. The beads were sonicated in a water bath sonicator
into suspension and centrifuged for one minute at 16,000
× g. The supernatant was removed by a pipette and 1 ml
of activation buffer (0.1 M NaH2PO4, pH 6.2) added to
the pellet and vortexed to re-suspend. In separate tubes
Sulfo_NHS and EDC were reconstituted to 50 mg/ml and
125 μl of each added to the beads, vortexed and incubated
at room temperature for twenty minutes with inversions
in the dark. The beads were centrifuged for one minute at
16,000 × g, re-suspended in 1 ml of 50 mM MES pH 5.0,
centrifuged for one minute at 16,000 × g and the superna-
tant removed. The MES wash was repeated. The beads
were re-suspended in 500 μl of MES. In separate tubes, the
different protein samples (100 μg of each) were mixed
with MES to a final volume of 500 μl and each was added
to a separate bead population and incubated at room tem-
perature for two hours in the dark with inversions. The
beads were centrifuged for one minute at 16,000 × g and
the supernatant removed. The beads were washed twice in
1 ml of PBS/TBN (0.02% Tween-20, 0.1% BSA and 0.05%
sodium azide in PBS pH 7.4. The beads were re-suspended
in 1 ml of PBS/TBN and stored at 4°C in the dark. To
determine if coupling was effective, aliquots of the differ-
ent bead sets were prepared for analysis as described
below and analysed on the BioPlex100  system.
Analysis of coupled beads on the BioPlex100 system
The coated beads were diluted 1:333 in Assay Buffer E
(ABE buffer: 0.1% BSA, 0.05% Tween-20, 0.05% sodium
azide in PBS pH 7.4) and 50 μl aliquots of were dispensed
into the wells of a 1.2 μm filter bottom 96-well microtiter
plate (MSBVS 1210, Millipore, USA) pre-wetted with ABE
buffer. The beads in 96-well plates were washed three
times with ABE using a vacuum manifold (Millipore,
USA). Frozen plasma samples were thawed at room tem-
perature, mixed by vortexing, and spun at 16,000 × g for
five minutes to remove particulates. Plasma samples were
diluted 1:80 in ABE buffer and 50 μl aliquots of diluted
sample was added to the beads and incubated in the dark
on a shaking platform at 1100 rpm for thirty seconds fol-
lowed by 300 rpm for thirty minutes. Excess antibody was
removed using a vacuum manifold followed by three
washes in ABE. 25 μl of biotinylated human IgG detection
antibody diluted 1:500 in ABE was added to the beads,
incubated in the dark with shaking at 1100 rpm for thirty
seconds followed by 300 rpm for thirty minutes and
washed three times in ABE. 50 μl of phycoerythrin-conju-
gated streptavidin diluted 1:500 in ABE was added to the
beads and incubated in the dark with shaking at 1100 rpm
for thirty seconds followed by 300 rpm for ten minutes.
Excess phycoerythrin conjugated streptavidin was
removed followed by three washes in ABE. The beads were
then re-suspended in 125 μl of ABE and analysed on the
BioPlex100 system. The reader was set to read a minimum
of 100 beads with identical unique detection signal and
the results were expressed as median fluorescent intensity
(MFI). In order to determine whether the human IgG
detection antibody bound non-specifically to the coated
beads, the beads were analysed against naïve plasma sam-
ple from Danes who have not been exposed to malaria.
Multiplexing and lyophilization of beads
Equal volumes of the coated beads were pooled together
and mixed by vortexing. This bead mix was divided in half
and one half was stored at 4°C in the dark. Sucrose and
Tween 20 were added to the other half to 3% and 0.05%
respectively, mixed by vortexing and single-use aliquots
were lyophilized (adVantage, Wizad™ 2.0, Virtis) in poly-
propylene vials, sealed under nitrogen gas and stored at -
80°C. Immediately prior to use, lyophilized beads were
reconstituted with distilled water and used for analysis as
described above.
Enzyme-linked immunosorbent assay (ELISA)
Antibody reactivity levels to the recombinant PfEMP1
proteins were measured in an ELISA system as described
by Jensen et al [11]. The wells of Maxisorp microtitre
plates (Nunc, Roskilde, Denmark) were coated by over-
night incubation at 4°C with 100 μl of the recombinant
PfEMP1 protein (5 μg/ml) diluted in 0.1 M glycine-HCl
(pH 2.75). The plates were emptied and any residual
binding sites were blocked by addition of 200 μl of block-
ing buffer (1% BSA, 0.5 M NaCl, 1% Triton X-100, in
phosphate buffered saline (PBS) pH 7.2) per well fol-
lowed by thirty minutes incubation at room temperature
on a shaker. 100 μl of plasma sample diluted 1:80 in
blocking buffer was added in duplicate wells and incu-
bated for one hour at room temperature on a shaker. Fol-
lowing four washes in wash buffer (0.5 M NaCl, 1%
Triton X-100 in PBS pH 7.4), the plates were incubated for
thirty minutes at room temperature with 100 μl per well
of peroxidase-conjugated goat anti-human IgG (Dako,
Glostrup, Denmark) diluted 1:3000 in blocking buffer.
The plates were washed four times in wash buffer and 100
μl of o-phenylenediamine substrate (Dako) activated with
H2O2 was added to each well. The plates were incubated
in the dark at room temperature before adding 100 μl of
2.5 M H2SO4. Optical densities were measured at 492 nm
(OD492). All samples were analysed in duplicate. On each
assay microtiter plate, a reference positive control plasma
pool was included in addition to negative control wells
without plasma (background levels). Results were calcu-
lated as arbitrary ELISA units (EU) to account for plate-to-
plate variation as described by Jensen et al [12]:Malaria Journal 2008, 7:108 http://www.malariajournal.com/content/7/1/108
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These same samples were analysed by the bead-based
assay and the results compared to those from ELISA.
Results
Protein-coupled beads are recognized by hyper-immune 
plasma
Effective coupling of protein was determined by analysing
the coupled bead populations against pooled hyper-
immune plasma of ten Liberian individuals and pooled
naïve plasma of twenty Danes on the BioPlex100 system.
Comparing the MFI obtained for each coupled domain
analysed against both plasma pools showed a signifi-
cantly higher MFI value for the pooled hyper-immune
plasma in all cases (Figure 1). In addition the MFI values
for the pooled naïve plasma were generally similar across
the different bead population but varied in the case of the
pooled hyper-immune plasma (Figure 1), suggesting het-
erogeneity in the levels of antibodies against the individ-
ual recombinant PfEMP1 proteins.
Relationship between ELISA and bead-based assay
Four recombinant PfEMP1 proteins C17, D5, D9 and D12
selected on the basis that they showed a spread of MFI val-
ues from low to high when analysed by the bead-based
assay were chosen for this analysis. The results obtained
from measuring antibody reactivity to these four proteins
in eighty plasma samples (twenty individuals from each
of three Tanzanian villages Mgome, Ubiri and Magamba
and twenty Danes) by the bead-based assay were com-
pared to those obtained by ELISA (Figure 2). For both
analyses, the plasma samples were diluted 1:80. The
Spearman's rank correlation coefficients (Rho) were ≥
0.86, (P < 0.0001) for all comparisons. A detailed analysis
to compare the sensitivity of ELISA and bead-based assay
was not done. Using a cut off of mean plus two standard
deviations of the value in the Danish control plasma, the
percentage of responders amongst the African individuals
were 70.0% vs. 66.6%, 48.3% vs. 65.0%, 63.3% vs.
71.7%, 86.7% vs. 48.3% in the bead-based assay vs. ELSA
for proteins C17, D9, D12 and D5 respectively.
Impact of multiplexing on protein-specific reactivity
To investigate the effect of multiplexing on antibody reac-
tivity, the reactivity of pooled hyper-immune plasma with
the coupled beads was measured in single and multiplex
formats. The results from both were compared. The pro-
tein-specific MFI values obtained in each assay were close
to identical, Spearman's rank correlation coefficient (Rho)
= 0.97, (P < 0.0001)(Figure 3), indicating that in the mul-
tiplex format, the individual proteins on the beads do not
compete for the available antibodies in the sample.
Stability of protein-coated beads at 4°C
To determine the stability of the coupled beads after stor-
age in the dark at 4°C, five protein-specific beads were
analysed against the pooled hyper-immune plasma
immediately after coupling (white bars) and after seven
months of storage (black bars) and the MFI values from
the two time points were compared (Figure 4). A slight
decrease in MFI values after storage at 4°C was observed
for all beads.
Stability of protein-coated beads after lyophylization
To investigate the stability of the coupled beads after
lyophilization the pooled hyper-immune plasma was
ODsample ODbackground
ODreference pool ODbackground
−
−
×100%
Antibody reactivity to twenty eight recombinant PfEMP1 proteins in human plasma Figure 1
Antibody reactivity to twenty eight recombinant PfEMP1 proteins in human plasma. Twenty eight recombinant 
PfEMP1 proteins coupled onto beads with unique detection signals were analysed using a bead-based assay against a pooled 
hyper-immune plasma (white bars) and a pooled naïve plasma from Danish donors (black bars). The results were expressed as 
median fluorescent intensity (MFI).
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screened with both lyophilized and non lyophilized cou-
pled beads in a multiplex format and essentially identical
results were obtained, Spearman's rank correlation coeffi-
cient (Rho) = 0.99, (P < 0.0001) (Figure 5). The inter-
assay CV when measured in a single well immediately
after lyophilization, three and six months later was within
the limit reported below indicating stability of the lyophi-
lized beads over time with storage at -80°C.
Inter-assay and intra-assay variation for the bead-based 
assay
Inter-assay and intra-assay variation expressed as coeffi-
cient of variation (CV) were determined using the pooled
hyper-immune plasma. The inter-assay CV was 13.4%
when measured in a single well on ten consecutive plates.
The intra-assay CV was 8.0% when measured in eight
wells on a single plate.
Discussion
One of the major challenges faced by researchers dealing
with malaria in young children is the limited amount of
Comparison of the bead-based assay and ELISA Figure 2
Comparison of the bead-based assay and ELISA. Four recombinant PfEMP1 proteins (C17, D5, D9 and D12) were ana-
lysed by ELISA and by the bead-based assay using twenty plasma samples from Danish donors and plasma samples from 60 indi-
viduals living in the three Tanzania villages Mgome (high malaria transmission), Ubiri (medium malaria transmission) and 
Magamba (low malaria transmission). The samples for both assay platforms were diluted 1:80 and results were expressed as 
median fluorescent intensity for the bead-based assay and arbitrary ELISA Units for ELISA. The Spearman's rank correlation 
coefficients (Rho) were ≥ 0.86, (P < 0.0001). Note: The graphs have different scales. MFI: median fluorescent intensity and EU: 
ELISA units.Malaria Journal 2008, 7:108 http://www.malariajournal.com/content/7/1/108
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plasma volume easily obtainable from infants and tod-
dlers. Immunoassays such as ELISA require approximately
1 μl of sample for each analyte. In contrast, the multiplex
assay has a major advantage of being able to theoretically
analyse one hundred antigens simultaneously in 1 μl of
sample. Fouda et al [7] reported a multiplex assay for
measuring antibodies to nine P. falciparum malaria pro-
teins. The multiplex assay described here measures anti-
body recognition to twenty eight recombinant P.
falciparum  erythrocyte membrane protein 1 (PfEMP1)
proteins simultaneously in 1 μl of plasma sample. To
demonstrate effective coupling, the coated beads were
analysed individually against pooled hyper-immune
plasma (Liberian individuals) and pooled naïve plasma
(Danes) and were able to show a significantly higher rec-
ognition of the pooled hyper-immune plasma compared
to the pooled naïve plasma for each individual coated
bead (Figure 1). These results suggest that the recom-
binant PfEMP1 proteins were effectively coupled onto the
beads.
Jacobsen [13] suggested guidelines for intra and inter-
assay coefficients of variation of <10% and <20% respec-
tively for bead-based assays. The bead-based assay
reported here has intra- and inter-assay coefficients of var-
iation of 8% and 13.4% respectively, well within the range
suggested. Previous studies [7,14] suggest that the bead-
based assay is more sensitive than ELISA in measuring
antibody recognition in human plasma samples. For the
protein D5, the sensitivity of the bead-based assay seemed
to be markedly higher than in the corresponding ELISA
assay, but for the three other proteins, the sensitivity of the
ELISA assay seemed to be at level with or even a bit higher
than the corresponding bead-based assay. The main dif-
ference between the results obtained in the two assays was
seen in samples with high levels of antibodies, where
ELISA readings seemed to have reached a sealed maximal
value before the bead-based assay. In a few samples, there
was a marked difference between the ELISA and bead-
based assay readings (relatively low ELISA value/high
Comparison of single bead and multiplex analysis Figure 3
Comparison of single bead and multiplex analysis. 
Twenty eight recombinant PfEMP1 proteins coupled beads 
were analysed against the pooled hyper-immune plasma in 
single and multiplex formats. The results from both experi-
ments were expressed as median fluorescent intensity (MFI). 
The Spearman's rank correlation coefficient (Rho) and P-
value are shown.
The effect of long term storage at 4°C in the dark on coupled  beads Figure 4
The effect of long term storage at 4°C in the dark on 
coupled beads. The median fluorescent intensity (MFI) val-
ues for five coupled bead populations were measured on the 
BioPlex100 system against the pooled hyper-immune plasma 
just after coupling (white bars) and seven months later (black 
bars).
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Comparison of lyophilized and non lyophilized multiplexes Figure 5
Comparison of lyophilized and non lyophilized multi-
plexes. The median fluorescent intensity (MFI) values for 
each coupled bead population in a multiplex of all twenty 
eight beads analysed against the pooled hyper-immune 
plasma before and after lyophilization of the multiplex. The 
Spearman's rank correlation coefficient (Rho) and P-value are 
shown.Malaria Journal 2008, 7:108 http://www.malariajournal.com/content/7/1/108
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bead-based assay values or vise versa). This could be due
to the fact that different parts of the recombinant proteins
are accessible by antibodies when the proteins are bound
to a surface or a sphere. The major advantage of the bead-
based assay over ELISA is its ability to measure several
analytes simultaneously in a small volume of sample
[15,16]. However, antibody competition and or blocking
are to be expected if antigens that share antibody epitopes
are detected together in a multiplex. To check for these all
twenty eight PfEMP1 coupled beads were analysed in
both single and multiplex formats and did not identify
significant competition (Figure 3).
Stability of reagents is especially important if results are to
be compared over an extended period. It has been shown
that coupled beads remained stable for nine months with
storage at 4°C [17]. There was a decreasing trend in the
MFI values of coupled beads after storage at 4°C in the
dark for seven months (Figure 4). However this problem
can be resolved by lyophilizing the beads since MFI values
for lyophilized beads do not differ significantly from
those obtained using non-lyophilized beads (Figure 5).
The lyophilization step is a novel approach to maintain
the stability and extend the shelf life of coupled beads.
This provides a major advantage of reducing batch-to-
batch variation when for example analysing plasma sam-
ples that are collected over many years in longitudinal
studies.
Conclusion
The multiplex assay described here can measure simulta-
neously antibodies against twenty eight recombinant
PfEMP1 proteins in human plasma. The assay also uses
less sample volume, is faster and less labour intensive
compared to ELISA. The assay shows a novel approach for
maintaining the stability and extending the shelf life of
coated beads thus reducing batch-to-batch assay varia-
tion. Thus, the assay described here provides a useful tool
for studying the immunology of malaria especially in
young children where the plasma volume available is usu-
ally limited.
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